SenesTech, Inc. (SNES)
0.829
-0.01
(-0.71%)
USD |
NASDAQ |
Oct 06, 16:00
0.83
0.00 (0.00%)
After-Hours: 20:00
SenesTech EPS Diluted (Quarterly) : -0.3454 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3454 |
| March 31, 2026 | -0.3919 |
| December 31, 2025 | -0.3454 |
| September 30, 2025 | -0.2781 |
| June 30, 2025 | -0.8714 |
| March 31, 2025 | -1.281 |
| December 31, 2024 | -1.219 |
| September 30, 2024 | -2.074 |
| June 30, 2024 | -3.079 |
| March 31, 2024 | -3.561 |
| December 31, 2023 | -3.372 |
| September 30, 2023 | -55.94 |
| June 30, 2023 | -83.60 |
| March 31, 2023 | -158.88 |
| December 31, 2022 | -377.00 |
| September 30, 2022 | -519.98 |
| June 30, 2022 | -504.84 |
| March 31, 2022 | -458.42 |
| December 31, 2021 | -490.32 |
| Date | Value |
|---|---|
| September 30, 2021 | -443.57 |
| June 30, 2021 | -335.02 |
| March 31, 2021 | -537.10 |
| December 31, 2020 | -985.51 |
| September 30, 2020 | -1355.06 |
| June 30, 2020 | -1416.07 |
| March 31, 2020 | -4067.76 |
| December 31, 2019 | -4734.72 |
| September 30, 2019 | -4448.64 |
| June 30, 2019 | -4475.04 |
| March 31, 2019 | -4824.96 |
| December 31, 2018 | -5378.40 |
| September 30, 2018 | -6518.40 |
| June 30, 2018 | -12000.00 |
| March 31, 2018 | -7680.00 |
| December 31, 2017 | -7200.00 |
| September 30, 2017 | -13440.00 |
| June 30, 2017 | -16800.00 |
| March 31, 2017 | -16320.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Enveric Biosciences, Inc. | -0.7594 |
| LENZ Therapeutics, Inc. | -1.017 |
| Impact BioMedical, Inc. | -0.0818 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.832M |
| Revenue (Quarterly) | 0.77M |
| Total Expenses (Quarterly) | 2.602M |
| Enterprise Value | 1.896M |
| Gross Profit Margin (Quarterly) | 69.74% |
| Profit Margin (Quarterly) | -237.9% |
| Earnings Yield | -164.1% |
| Normalized Earnings Yield | -164.15 |